{"id":4799,"date":"2018-11-21T06:54:33","date_gmt":"2018-11-21T11:54:33","guid":{"rendered":"https:\/\/www.med.unc.edu\/neuroscience\/?p=4799"},"modified":"2018-11-21T08:19:34","modified_gmt":"2018-11-21T13:19:34","slug":"philpot-lab-publishes-in-the-journal-of-clinical-investigation","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/","title":{"rendered":"Philpot Lab publishes in the Journal of Clinical Investigation"},"content":{"rendered":"<h4>The UNC School of Medicine lab of Ben Philpot, PhD, discovered key details for how a deficiency in the gene UBE3A affects the brain and how replacing it could benefit children with the neuro-genetic disorder Angelman syndrome, a genetic disease with no cure.<\/h4>\n<p>Angelman syndrome is a genetic disease with no cure. Children grow up with severe intellectual disabilities and a range of other problems, arguably the worst of which are epileptic seizures. Now scientists at the UNC School of Medicine have found evidence that genetic therapy may prevent the enhanced seizure susceptibility.<\/p>\n<p><a class=\"external-link\" title=\"\" href=\"https:\/\/www.jci.org\/articles\/view\/120816\" target=\"_self\">Published in the<i> Journal of Clinical Investigation<\/i><\/a>, the research marks the first time scientists were able to reduce seizure susceptibility in mice by activating a dormant copy of the <i>UBE3A<\/i> gene so it could replace the faulty mutant version. While replacing the faulty gene in juveniles reduced seizures, replacing the faulty gene in adult mice had no effect.<\/p>\n<p>The UNC scientists also found evidence that the loss of this gene in Angelman syndrome promotes seizures by impairing the normal activity of inhibitory neurons \u2013 cells that normally keep brain circuits from being overstimulated.<\/p>\n<p>\u201cThese findings should be very useful in the development and testing of therapies for Angelman syndrome,\u201d said senior author Benjamin D. Philpot, PhD, Kenan Distinguished Professor in the Department of Cell Biology and Physiology, associate director of the UNC Neuroscience Center, and member of the UNC Autism Research Center.<\/p>\n<p>Angelman syndrome, named for the pediatrician who first described it in 1965, afflicts roughly one in 20,000 people, which implies that there are more than 16,000 people with the syndrome in the United States alone. The syndrome is caused by the loss of function of a single gene, <i>UBE3A<\/i>, but with an odd twist: the mutant or deleted copy of <i>UBE3A<\/i> is the one inherited from the patient\u2019s mother. This maternal copy is crucial in neurons because \u2013 for reasons still unknown \u2013 the paternal copy of <i>UBE3A<\/i> is silenced in these cells via a mechanism called genomic imprinting.<\/p>\n<p><i>UBE3A<\/i> encodes<i> <\/i>a protein that works in an important cellular waste-disposal and gene-regulating system. Precisely how the absence of this protein in neurons causes Angelman syndrome has never been clear. Even so, scientists have been working on candidate therapies to restore <i>UBE3A<\/i> activity in neurons, thereby preventing or reversing some or all of the features of the disease. Among these features is epilepsy, which afflicts about 90 percent of Angelman syndrome patients, who typically do not respond well to standard anti-seizure medications.<\/p>\n<p>Some aspects of the disease reflect abnormal prenatal and early postnatal development, and may never be reversible with treatments that start years after birth. But epilepsy often doesn\u2019t start in Angelman patients until age 2 or 3, suggesting that early life replacement of <i>UBE3A<\/i> might cure it or prevent it. Philpot and colleagues decided to investigate how early the gene reinstatement needed to take place. They took advantage of an Angelman syndrome mouse model, in which researchers inserted a working copy of the <i>UBE3A<\/i> gene that would lie dormant in brain cells until scientists turned it on with a chemical switch.<\/p>\n<p>The scientists found that switching on <i>UBE3A<\/i> failed to prevent or reverse the high susceptibility to seizures in adult Angelman mice. However, switching on the gene when the mice were just three weeks old made them as resistant to seizures as ordinary mice.<\/p>\n<dl class=\"image-left captioned\">\n<dt><img loading=\"lazy\" decoding=\"async\" title=\"Bin Gu_philpot lab\" src=\"http:\/\/news.unchealthcare.org\/images\/portraits\/faculty\/bin-gu_philpot-lab\/@@images\/988ce30e-9c87-469c-877e-04dc7852a539.jpeg\" alt=\"Bin Gu_philpot lab\" width=\"122\" height=\"218\" \/><\/dt>\n<dd class=\"image-caption\">Bin Gu, PhD<\/dd>\n<\/dl>\n<p>\u201cThree weeks of age for a mouse corresponds to early childhood for a human, so this suggests that there may be a window of opportunity in childhood for the prevention of Angelman syndrome epilepsy,\u201d said first author Bin Gu, PhD, a postdoctoral researcher in the Philpot Lab who performed most of the key experiments.<\/p>\n<p>Another big question for Angelman syndrome researchers has to do with the neurons affected by the disease. Philpot wondered, to treat the condition successfully, would <i>UBE3A<\/i> activity need to be restored in all types of neurons or just in some?<\/p>\n<p>Philpot\u2019s team removed functional <i>UBE3A<\/i> from excitatory neurons \u2013 which trigger activity in connected neurons \u2013 and observed that the resulting mice were unaffected. Then they blocked the gene just in inhibitory neurons, whose activity normally quiets and regulates connected neurons, thereby preventing the neural hyperactivity that can trigger seizures. With <i>UBE3A<\/i> gone from the inhibitory neurons, the mice became even more susceptible to seizures than if <i>UBE3A<\/i> were absent from all neurons.<\/p>\n<p>\u201cThis result implies that if you want to limit epilepsy in Angelman syndrome, you\u2019ll need at least to restore the function of <i>UBE3A<\/i> in inhibitory neurons,\u201d Philpot said.<\/p>\n<p>The researchers gained another clue to the mechanism of Angelman syndrome seizures when they examined the brains of the seizure-prone mice, particularly in an area of the brain known as the hippocampus. They detected an abnormal accumulation of perineuronal nets (PNNs) \u2013 structures that surround neurons and block them from making new connections. Abnormal PNN formation has previously been linked to seizures. The scientists found that the abnormal PNN deposition did not occur in the young mice where <i>UBE3A<\/i> activity had been restored.<\/p>\n<p>\u201cWe can now think of these abnormal PNNs as biomarkers for enhanced seizure susceptibility,\u201d Philpot said. \u201cWe now want to determine if these structures actually cause seizure susceptibility, for example by disrupting the connections that inhibitory neurons normally would make in this brain region.\u201d<\/p>\n<p>Philpot and collaborators at UNC, along with other researchers elsewhere, are working on potential Angelman syndrome treatments, including drugs that would activate the previously silenced paternal copy of <i>UBE3A<\/i> in brain cells.<\/p>\n<p><i>The American Epilepsy Society, the Angelman Syndrome Foundation, and the National Institutes of Health funded this research.<\/i><\/p>\n<p>Media contact: Mark Derewicz, 984-974-1915, <a href=\"mailto:mark.derewicz@unchealth.unc.edu\">mark.derewicz@unchealth.unc.edu<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The UNC School of Medicine lab of Ben Philpot, PhD, discovered key details for how a deficiency in the gene UBE3A affects the brain and how replacing it could benefit children with the neuro-genetic disorder Angelman syndrome, a genetic disease with no cure. Angelman syndrome is a genetic disease with no cure. Children grow up &hellip; <a href=\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/\" aria-label=\"Read more about Philpot Lab publishes in the Journal of Clinical Investigation\">Read more<\/a><\/p>\n","protected":false},"author":9509,"featured_media":3141,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[],"class_list":["post-4799","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Philpot Lab publishes in the Journal of Clinical Investigation | UNC Neuroscience Center<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Philpot Lab publishes in the Journal of Clinical Investigation | UNC Neuroscience Center\" \/>\n<meta property=\"og:description\" content=\"The UNC School of Medicine lab of Ben Philpot, PhD, discovered key details for how a deficiency in the gene UBE3A affects the brain and how replacing it could benefit children with the neuro-genetic disorder Angelman syndrome, a genetic disease with no cure. Angelman syndrome is a genetic disease with no cure. Children grow up &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/\" \/>\n<meta property=\"og:site_name\" content=\"UNC Neuroscience Center\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-21T11:54:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-11-21T13:19:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"266\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uncneuro\" \/>\n<meta name=\"twitter:site\" content=\"@uncneuro\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Philpot Lab publishes in the Journal of Clinical Investigation\",\"datePublished\":\"2018-11-21T11:54:33+00:00\",\"dateModified\":\"2018-11-21T13:19:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/\"},\"wordCount\":963,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/\",\"url\":\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/\",\"name\":\"Philpot Lab publishes in the Journal of Clinical Investigation | UNC Neuroscience Center\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg\",\"datePublished\":\"2018-11-21T11:54:33+00:00\",\"dateModified\":\"2018-11-21T13:19:34+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg\",\"width\":266,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/neuroscience\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Philpot Lab publishes in the Journal of Clinical Investigation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/neuroscience\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/neuroscience\/\",\"name\":\"UNC Neuroscience Center\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/neuroscience\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/www.med.unc.edu\/neuroscience\/author\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Philpot Lab publishes in the Journal of Clinical Investigation | UNC Neuroscience Center","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/","og_locale":"en_US","og_type":"article","og_title":"Philpot Lab publishes in the Journal of Clinical Investigation | UNC Neuroscience Center","og_description":"The UNC School of Medicine lab of Ben Philpot, PhD, discovered key details for how a deficiency in the gene UBE3A affects the brain and how replacing it could benefit children with the neuro-genetic disorder Angelman syndrome, a genetic disease with no cure. Angelman syndrome is a genetic disease with no cure. Children grow up &hellip; Read more","og_url":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/","og_site_name":"UNC Neuroscience Center","article_published_time":"2018-11-21T11:54:33+00:00","article_modified_time":"2018-11-21T13:19:34+00:00","og_image":[{"width":266,"height":400,"url":"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@uncneuro","twitter_site":"@uncneuro","twitter_misc":{"Written by":"","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/"},"author":{"name":"","@id":""},"headline":"Philpot Lab publishes in the Journal of Clinical Investigation","datePublished":"2018-11-21T11:54:33+00:00","dateModified":"2018-11-21T13:19:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/"},"wordCount":963,"image":{"@id":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/","url":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/","name":"Philpot Lab publishes in the Journal of Clinical Investigation | UNC Neuroscience Center","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/neuroscience\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg","datePublished":"2018-11-21T11:54:33+00:00","dateModified":"2018-11-21T13:19:34+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#primaryimage","url":"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg","contentUrl":"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg","width":266,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/neuroscience\/philpot-lab-publishes-in-the-journal-of-clinical-investigation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/neuroscience\/"},{"@type":"ListItem","position":2,"name":"Philpot Lab publishes in the Journal of Clinical Investigation"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/neuroscience\/#website","url":"https:\/\/www.med.unc.edu\/neuroscience\/","name":"UNC Neuroscience Center","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/neuroscience\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"","url":"https:\/\/www.med.unc.edu\/neuroscience\/author\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg","featured_image_medium":"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2-200x300.jpeg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg","featured_image_large":"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2.jpeg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/neuroscience\/wp-content\/uploads\/sites\/782\/2018\/07\/philpot-lab-publishes-research-in-neuron-image2-150x150.jpeg","featured_image_alt":"","category_details":[{"name":"News","link":"https:\/\/www.med.unc.edu\/neuroscience\/category\/news\/"}],"tag_details":[],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/neuroscience\/wp-json\/wp\/v2\/posts\/4799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/neuroscience\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/neuroscience\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/neuroscience\/wp-json\/wp\/v2\/users\/9509"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/neuroscience\/wp-json\/wp\/v2\/comments?post=4799"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/neuroscience\/wp-json\/wp\/v2\/posts\/4799\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/neuroscience\/wp-json\/wp\/v2\/media\/3141"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/neuroscience\/wp-json\/wp\/v2\/media?parent=4799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/neuroscience\/wp-json\/wp\/v2\/categories?post=4799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/neuroscience\/wp-json\/wp\/v2\/tags?post=4799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}